Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
The Gross Law Firm Notifies Shareholders of Moderna, Inc.(MRNA) of a Class Action Lawsuit and an Upcoming Deadline
05:45am, Thursday, 15'th Aug 2024
NEW YORK , Aug. 15, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Moderna, Inc. (NASDAQ: MRNA). Shareholders who purchased shares of MRNA during the class peri
Contact Levi & Korsinsky by October 8, 2024 Deadline to Join Class Action Against Moderna, Inc.(MRNA)
01:05am, Thursday, 15'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 15, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, foll
Moderna Inc Investors Invited To Join Fraud Investigations With The Schall Law Firm
12:50am, Thursday, 15'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 15, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Moderna, Inc.
Shareholders that lost money on Moderna, Inc.(MRNA) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
09:30pm, Wednesday, 14'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 14, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, foll
NEW YORK, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Moderna, Inc.
Investors who lost money on Moderna, Inc.(MRNA) should contact Levi & Korsinsky about pending Class Action - MRNA
08:30pm, Wednesday, 14'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 14, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, foll
NEW YORK , Aug. 14, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed ag
Moderna, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 8, 2024 to Discuss Your Rights - MRNA
01:30pm, Wednesday, 14'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 14, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, foll
Stockholder Alert: Robbins LLP Informs Moderna, Inc. Stockholders that a Shareholder Filed a Class Action Against MRNA
01:11pm, Wednesday, 14'th Aug 2024
SAN DIEGO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Moderna,
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm
12:50pm, Wednesday, 14'th Aug 2024
LOS ANGELES, Aug. 14, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Moderna, Inc. (“Moderna” or
NEW YORK, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA) of a class action securities lawsuit.
These 3 stock sectors to rival AI in 2025, according to ChatGPT-4o
12:19pm, Wednesday, 14'th Aug 2024
As artificial intelligence (AI) continues to dominate headlines and portfolios, investors are looking ahead to identify other sectors that could rival AI in growth and innovation in the coming years.
Levi & Korsinsky Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MRNA
07:15am, Wednesday, 14'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 14, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, foll
Moderna and Coursera Launch Free Course on mRNA Technology
07:00am, Wednesday, 14'th Aug 2024
Companies share joint commitment to leveraging technology for STEM education Accessible education on cutting-edge science and technology represents critical step toward closing workforce readiness gap
NEW YORK, NY / ACCESSWIRE / August 14, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Moderna, Inc.
